HessDR. Aerosol therapy during noninvasive ventilation or high-flow nasal cannula. Respir Care, 2015; 60(6):880-891; discussion 891–883.
2.
LiJ, TuM, YangL, JingG, FinkJB, BurtinC, et al. Worldwide clinical practice of high-flow nasal cannula and concomitant aerosol therapy in the adult ICU setting. Respir Care, 2021; 66(9):1416-1424.
3.
LiJ, WilliamsL, FinkJ. The impacts of high-flow nasal cannula device, nebulizer type, and placement on transnasal aerosol drug delivery: an in-vitro study. Respir Care, 2022; 67(1)1-8.
4.
DugernierJ, HesseM, VanbeverR, DepoortereV, RoeselerJ, MichotteJB, et al. SPECT-CT comparison of lung deposition using a system combining a vibrating mesh nebulizer with a valved holding chamber and a conventional jet nebulizer: a randomized crossover study. Pharm Res, 2017; 34(2):290-300.
5.
DugernierJ, WitteboleX, RoeselerJ, MichotteJB, SottiauxT, DugernierT, et al. Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating mesh nebulizer during invasive mechanical ventilation: an in vitro analysis. J Aerosol Med Pulm Drug Deliv, 2015; 28(3):229-236.
6.
HwangPH, WooRJ, FongKJ. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol, 2006; 20(3):255-261.
7.
Le GuellecS, Le PennecD, GatierS, LeclercL, CabreraM, PourchezJ, et al. Validation of anatomical models to study aerosol deposition in human nasal cavities. Pharm Res, 2014; 31(1):228-237.
8.
NaclerioRM, BachertC, BaraniukJN. Pathophysiology of nasal congestion. Int J Gen Med, 2010; 3:47-57.
9.
BeuvonC, CoudroyR, BardinJ, MarjanovicN, RaultC, BironneauV, et al. Beta-agonist delivery by high-flow nasal cannula during COPD exacerbation. Respir Care, 2021; 67(1):9-15.
10.
BraunlichJ, WirtzH. Oral versus nasal high-flow bronchodilator inhalation in chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv, 2018; 31(4):248-254.
11.
CortegianiA, LonghiniF, CarlucciA, ScalaR, GroffP, BruniA, et al. High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials, 2019; 20(1):450.
12.
KuchBA, LinssenR, YoshikawaH, SmallwoodCD, DavisMD. Local effects of two intravenous formulations of pulmonary vasodilators on airway epithelium. Respir Care, 2020; 65(10):1427-1432.
13.
DavisMD, DonnSM, WardRM. Administration of inhaled pulmonary vasodilators to the mechanically ventilated neonatal patient. Paediatr Drugs, 2017; 19(3):183-192.
